Why the study?
Low-risk ABCD2 scores may fail to identify TIA patients with treatable high-risk conditions, raising concerns regarding predictive accuracy and the value of expanded clinical variables or neuroimaging.
Does the ABCD2 score accurately predict early and late stroke risk and distinguish TIA from mimics in patients with suspected TIA?
Does the ABCD2 score accurately predict early and late stroke risk and distinguish TIA from mimics in patients with suspected TIA?
The ABCD2 score has significant limitations in predicting stroke risk and differentiating TIA mimics, highlighting the need for comprehensive clinical assessment beyond simple scoring.
Answers are grounded in this paper and cite their sources.
Low ABCD2 scores may miss treatable high-risk TIA features; leaves open whether neuroimaging or expanded variables improve stratification.
The ABCD2 score is widely used for early stroke risk stratification following transient ischemic attack (TIA); however, a critical limitation is that low-risk scores may still fail to identify patients with treatable high-risk conditions, leading to missed opportunities for urgent intervention. This raises ongoing concerns about its predictive accuracy, applicability across diverse clinical settings, and the added value of incorporating neuroimaging or expanded clinical variables. A PRISMA-guided systematic review was performed, evaluating nine studies investigating the predictive performance and limitations of the ABCD2 score and its variants for early and late stroke risk, as well as their ability to distinguish TIA from mimics. Across 6,111 TIA patients and additional suspected-TIA cohorts, findings were heterogeneous. Several studies demonstrated only modest predictive accuracy, with the score performing best at identifying low-risk patients rather than reliably detecting those at highest risk. Importantly, multiple studies showed that patients with ABCD2 <4 still experienced clinically significant short-term stroke risk when underlying etiologies such as carotid stenosis or cardioembolism were present. Imaging-augmented variants (e.g., ABCD2-I, ABCD3-I) provided inconsistent or minimal incremental value. Moreover, up to 20% of suspected TIAs were mimics, and the ABCD2 score showed poor discriminatory ability in distinguishing them from true events. Although the ABCD2 score remains a practical initial tool for TIA triage, its limitations—including inconsistent predictive accuracy, inability to reliably identify all high-risk patients, and poor performance in differentiating mimics—underscore the need for comprehensive clinical assessment beyond simple scoring. Future large-scale prospective studies are required to validate augmented models and refine individualized risk-stratification strategies.
No takes yet. Share an insight, caveat, or question.
Buliman et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: